SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 64 filers reported holding SIO GENE THERAPIES INC in Q4 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $0 | – | 132 | -58.2% | 0.00% | – |
Q3 2022 | $0 | – | 316 | +754.1% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 37 | -99.9% | 0.00% | – |
Q1 2022 | $18,000 | +28.6% | 26,912 | +146.6% | 0.00% | – |
Q4 2021 | $14,000 | -83.9% | 10,915 | -66.1% | 0.00% | – |
Q3 2021 | $87,000 | -1.1% | 32,236 | 0.0% | 0.00% | – |
Q2 2021 | $88,000 | +69.2% | 32,236 | +59.1% | 0.00% | – |
Q1 2021 | $52,000 | -50.5% | 20,264 | -46.5% | 0.00% | – |
Q4 2020 | $105,000 | – | 37,863 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cladis Investment Advisory, LLC | 1,126,000 | $754,000 | 0.72% |
Prosight Management, LP | 670,300 | $449,000 | 0.29% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,914,000 | $3,962,000 | 0.12% |
ACT CAPITAL MANAGEMENT, LLC | 146,500 | $98,000 | 0.10% |
Rubric Capital Management LP | 3,000,000 | $2,010,000 | 0.07% |
Clearline Capital LP | 392,691 | $263,000 | 0.03% |
APOGEM CAPITAL LLC | 49,528 | $33,000 | 0.02% |
Hudson Bay Capital Management LP | 1,682,000 | $1,127,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 244,900 | $164,000 | 0.00% |
NORTHERN TRUST CORP | 87,153 | $58,000 | 0.00% |